MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Alan F. Cowman, Christopher W. Boyce et al.|EBioMedicine|2025Cited by 6
High Content Screening Applications for RNA TherapeuticsBonnie J. Howell, Laura Sepp‐Lorenzino, Edward Keough et al.|The FASEB Journal|2009Cited by 0